Variants in GIPR (rs1800437 is the headline variant for differential GLP-1 response), FTO (appetite regulation), MC4R (satiety signaling), and TCF7L2 (insulin response) are associated with measurably different response patterns to semaglutide and tirzepatide
N Engl J Med 380(24):22952306 Kristensen SL, Rrth R, Jhund PS, Docherty KF, Sattar N, Preiss D et al (2019) Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Better sleep, calmer appetite, a more confident routine, and a sense that you can do this for the long term are powerful outcomes during a weight loss journey
If itching is intense, persistent, or accompanied by hives, rash, or swelling, contact your prescriber immediatelythese may signal a true allergic reaction requiring medication discontinuation or switching to a different GLP-1 compound or delivery method
Medrol: Shares the same potential side effects as Prednisone